Criteria for deciding cost-effectiveness for expensive new anti-cancer agents.
J Cancer Res Ther
;
2008 Jan-Mar; 4(1): 1-2
Article
in English
| IMSEAR
| ID: sea-111571
Subject(s)
Full text:
Available
Index:
IMSEAR (South-East Asia)
Main subject:
Humans
/
Cost-Benefit Analysis
/
Neoplasms
/
Antineoplastic Agents
Type of study:
Health economic evaluation
Language:
English
Journal:
J Cancer Res Ther
Journal subject:
Neoplasms
/
Therapeutics
Year:
2008
Type:
Article
Similar
MEDLINE
...
LILACS
LIS